title: The Goeckerman regimen for the treatment of moderate to severe psoriasis.
abstract: Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 2-3% of the population. The Goeckerman regimen consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). Goeckerman therapy is extremely effective and relatively safe for the treatment of psoriasis and for improving a patient's quality of life. In the following article, we present our protocol for the Goeckerman therapy that is utilized specifically at the University of California, San Francisco. This protocol details the preparation of supplies, administration of phototherapy and application of topical tar. This protocol also describes how to assess the patient daily, monitor for adverse effects (including pruritus and burning), and adjust the treatment based on the patient's response. Though it is one of the oldest therapies available for psoriasis, there is an absence of any published videos demonstrating the process in detail. The video is beneficial for healthcare providers who want to administer the therapy, for trainees who want to learn more about the process, and for prospective patients who want to undergo treatment for their cutaneous disease.
authors.affiliation: Keck School of Medicine, University of Southern California, USA. rishugupta@gmail.com
authors.forename: Rishu
authors.initials: R
authors.lastname: Gupta
authors.forename: Maya
authors.initials: M
authors.lastname: Debbaneh
authors.forename: Daniel
authors.initials: D
authors.lastname: Butler
authors.forename: Monica
authors.initials: M
authors.lastname: Huynh
authors.forename: Ethan
authors.initials: E
authors.lastname: Levin
authors.forename: Argentina
authors.initials: A
authors.lastname: Leon
authors.forename: John
authors.initials: J
authors.lastname: Koo
authors.forename: Wilson
authors.initials: W
authors.lastname: Liao
mesh_terms: D003033:Coal Tar / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004501:Education, Medical / Q000379:methods; D006801:Humans; D010353:Patient Education as Topic / Q000379:methods; D011565:Psoriasis / Q000188:drug therapy* / Q000532:radiotherapy*; D014467:Ultraviolet Therapy / Q000379:methods*
chemical_list: D003033:Coal Tar
references.citation: J Am Acad Dermatol. 2009 Feb;60(2):348-9
references.pmid: 19150284
references.citation: J Invest Dermatol. 2010 Apr;130(4):953-61
references.pmid: 20016499
references.citation: J Am Acad Dermatol. 2010 Jan;62(1):114-135
references.pmid: 19811850
references.citation: J Am Acad Dermatol. 1999 Jul;41(1):51-9
references.pmid: 10411411
references.citation: J Invest Dermatol. 2013 Feb;133(2):377-85
references.pmid: 23014338
references.citation: J Am Acad Dermatol. 1983 Jul;9(1):59-65
references.pmid: 6886105
references.citation: J Am Acad Dermatol. 2011 May;64(5):1011-2
references.pmid: 21496720
references.citation: J Am Acad Dermatol. 1980 Dec;3(6):612-5
references.pmid: 7204678
references.citation: Arch Dermatol. 1981 Aug;117(8):465-8
references.pmid: 7259240
references.citation: J Dermatolog Treat. 2005 Apr;16(2):102-7
references.pmid: 16019624
references.citation: J Dermatolog Treat. 2013 Feb;24(1):2-6
references.pmid: 21797807
references.citation: J Cutan Med Surg. 2012 May-Jun;16(3):153-68
references.pmid: 22713438
references.citation: Acta Derm Venereol. 2011 Jun;91(4):447-51
references.pmid: 21537818
references.citation: Am J Clin Dermatol. 2012 Dec 1;13(6):365-74
references.pmid: 22967166
references.citation: Int J Dermatol. 2009 Jun;48(6):653-8
references.pmid: 19538381